VALIDITY AND USE OF A NON-PARALLEL INSULIN ASSAY FOR PHARMACOKINETIC STUDIES OF THE RAPID-ACTING INSULIN ANALOGUE, INSULIN ASPART

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of immunoassay & immunochemistry

• Publication date

  2001-06-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1081/IAS-100103226PMID 11486812
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A new insulin immunoassay specific for the rapid-acting insulin analog, insulin aspart, suitable for bioavailability, bioequivalence, and pharmacokinetic studies.

  2000cited by this paper
• Insulin Degradation In Vitro and In Vivo: A Comparative Study in Men: Evidence That Immunoprecipitable, Partially Rebindable Degradation Products Are Released From Cells and Circulate in Blood

  1994cited by this paper
• Enzyme immunoassay for intact human insulin in serum or plasma.

  1993influential reference
• Superiority of sandwich ELISA over competitive RIA for the estimation of ANP-270, an analogue of human atrial natriuretic factor.

  1992cited by this paper
• In Vitro and In Vivo Potency of Insulin Analogues Designed for Clinical Use

  1991cited by this paper
• Monomeric Insulins and Their Experimental and Clinical Implications

  1990cited by this paper
• Monomeric insulins obtained by protein engineering and their medical implications

  1988cited by this paper
• Human Insulin

  1986cited by this paper
• [Biological standardization].

  1972cited by this paper

• Development and validation of an electrochemiluminescent ELISA for quantitation of oral insulin tregopil in diabetes mellitus serum.

  2017cites this paper
• Subcutaneous insulin therapy - end of the road after 80 years?

  2014cites this paper
• Insights in regulated bioanalysis of human insulin and insulin analogs by immunoanalytical methods.

  2011cites this paper
• Analogues et dosages d’insuline : le cas général et le cas particulier de la glargine

  2010cites this paper
• Statistical Correction for Non‐parallelism in a Urinary Enzyme Immunoassay

  2004influential citation
• Estimation of "needs" and "probable uptake" for HIV/AIDS preventive vaccines based on possible policies and likely acceptance (a WHO/UNAIDS/IAVI study).

  2003cites this paper
• Comparative effect of human soluble insulin and insulin aspart upon hypoglycaemia-induced alterations in cardiac repolarization.

  2003cites this paper
• A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes.

  2002cites this paper
• Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes.

  2002cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Insulin Aspart

  2001cites this paper
• A new insulin immunoassay specific for the rapid-acting insulin analog, insulin aspart, suitable for bioavailability, bioequivalence, and pharmacokinetic studies.

  2000cites this paper